Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
about
Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a reviewCentenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems.Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.Plasma acylcarnitines are associated with physical performance in elderly menEfficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial.A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array.Water-soluble cationic derivatives of indirubin, the active anticancer component from Indigo naturalis.The Essentials of a Global Index for Cognitive Function.Carnitine deficiency and its possible risk factors in TB patients: first report.Scientific Opinion on the substantiation of health claims related to acetyl-L-carnitine and contribution to normal cognitive function (ID 1432) pursuant to Article 13(1) of Regulation (EC) No 1924/2006The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.l-Carnitine Supplementation in Recovery after Exercise.Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients.
P2860
Q26998916-CDDC8530-3204-4004-A7D7-04B814C42AA0Q34485678-6E643DC6-2F42-4D28-81FB-C4E13EA00406Q34680436-6E3F79BB-23F4-42C4-9655-518704FBB7BDQ34783612-27D33017-3E87-4760-9175-E1568A69AEE4Q37427021-493A4ED4-0B35-40D6-9634-8B2358E41607Q37582203-9A7C9142-00C5-4214-A9F9-045A90898EA9Q37698595-7FC0BFFB-4F55-41D1-AA8E-3218D677A653Q39256558-60B1A85E-7567-442C-A02F-54D718B630ACQ41111155-FFEF3921-5210-4968-ADD6-E7869E6B1873Q42249006-C58BCDF7-51D2-47AD-925C-7EFD32DFCAA7Q47150105-F0E210F3-4452-46D9-A6A7-E21B3DE3781DQ48146067-3008D895-84FB-4F67-869F-4FEC76E2BB2AQ51763575-56687B83-9C0F-4AAC-B5D5-DF12DCCF8FBDQ51848860-504E23F7-4EB5-4EB3-98C4-BF8F8261402E
P2860
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
@ast
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
@en
Acetyl L-carnitine
@nl
type
label
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
@ast
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
@en
Acetyl L-carnitine
@nl
prefLabel
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
@ast
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
@en
Acetyl L-carnitine
@nl
P2093
P50
P1476
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue
@en
P2093
Aleardo Koverech
Erika Cristaldi
Lisa Cammalleri
Maria Pia Gargante
Masa Messano
Massimo Motta
Valentina Colonna
P304
P356
10.1016/J.ARCHGER.2007.03.012
P577
2007-07-20T00:00:00Z